Anti-Obesity Drugs

Anti-obesity medication and weight loss drugs  are pharmacological mediators which lessen or control weight. These drugs modify one of the central processes of the human body or weight regulation by varying either appetite or absorption of calories. The treatment modalities for overweight and obese individuals remain dieting and physical exercise. Because the human body uses various chemicals and hormones to protect its stores of fat reaction probably useful to our ancestors when food was scarce in the past. Anti-obesity drugs are pharmaceutical agents designed to assist in weight loss by targeting various physiological mechanisms that regulate appetite, fat absorption, and metabolism. These medications are typically prescribed when lifestyle interventions such as diet and exercise have not been sufficiently effective, especially in individuals with obesity-related health conditions like type 2 diabetes, hypertension, or cardiovascular disease. Some of the most common anti-obesity drugs work by suppressing appetite, altering the brain's perception of hunger, or blocking the absorption of dietary fats in the intestines. These drugs are often used in combination with lifestyle modifications to achieve more substantial and sustained weight loss, While anti-obesity drugs can be effective in helping individuals achieve and maintain weight loss, they are not without risks. Potential side effects may include gastrointestinal issues, increased heart rate, and potential psychological effects such as mood changes. Moreover, the effectiveness of these drugs varies among individuals, and weight regain after discontinuation is a common challenge. Therefore, these medications are usually prescribed with caution, and their use is closely monitored by healthcare professionals. The development of newer drugs with better efficacy and safety profiles continues to be an area of active research, reflecti, The supreme anti-obesity drug would produce sustained weight loss with minimal side effects. The mechanisms that control energy balance have substantial built-in redundancy, overlap considerably with other physiological functions, and are influenced by social, hedonic and psychological factors that limit the effectiveness of pharmacological interventions.

    Related Conference of Anti-Obesity Drugs

    November 18-19, 2024

    4th World Summit on Obesity and Weight Management

    Paris, France
    November 27-28, 2024

    10th International Conference on Gynecology and Obstetrics

    Amsterdam, Netherlands
    November 28-29, 2024

    25th Annual Meet on Obesity and Diet

    Bali, Indonesia
    November 28-29, 2024

    23rd International Conference on Obesity

    Paris, France
    March 13-14, 2025

    8th International Conference on Obesity and Chronic Diseases

    Prague, Czech Republic
    March 24-25, 2025

    27th Global Obesity Meeting

    London, UK
    June 02-03, 2025

    21st Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands

    Anti-Obesity Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in